Comparison of dosing strategies in obese patients prescribed intravenous acyclovir and evaluation of rate of acute kidney injury

There is limited guidance on the most appropriate dosing strategy for intravenous (IV) acyclovir in obese patients. The manufacturer's labelling suggests using ideal body weight (IBW); however, previous pharmacokinetic studies of obese patients have shown more rapid systemic clearance and lower...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of antimicrobial agents 2023-08, Vol.62 (2), p.106871-106871, Article 106871
Hauptverfasser:	Zelnicek, Taylor D., Siegrist, Emily A., Miller, Jamie L., Neely, Stephen B., Higuita, Nelson Ivan Agudelo, White, Bryan P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acyclovir Adjusted body weight Ideal body weight Nephrotoxicity Obese
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!